Novo Nordisk A/S (NVO)
132.41
+3.99
(+3.11%)
USD |
NYSE |
May 13, 16:00
132.36
-0.05
(-0.04%)
After-Hours: 20:00
Novo Nordisk Market Cap: 589.86B for May 13, 2024
Market Cap Chart
Historical Market Cap Data
Date | Value |
---|---|
May 13, 2024 | 589.86B |
May 10, 2024 | 572.09B |
May 09, 2024 | 573.16B |
May 08, 2024 | 564.38B |
May 07, 2024 | 567.06B |
May 06, 2024 | 555.03B |
May 03, 2024 | 548.93B |
May 02, 2024 | 553.26B |
May 01, 2024 | 576.41B |
April 30, 2024 | 572.40B |
April 29, 2024 | 566.05B |
April 26, 2024 | 565.92B |
April 25, 2024 | 561.19B |
April 24, 2024 | 562.84B |
April 23, 2024 | 573.90B |
April 22, 2024 | 558.83B |
April 19, 2024 | 547.45B |
April 18, 2024 | 547.65B |
April 17, 2024 | 555.59B |
April 16, 2024 | 550.78B |
April 15, 2024 | 552.78B |
April 12, 2024 | 555.51B |
April 11, 2024 | 559.50B |
April 10, 2024 | 557.41B |
April 09, 2024 | 557.09B |
Date | Value |
---|---|
April 08, 2024 | 568.69B |
April 05, 2024 | 561.55B |
April 04, 2024 | 553.10B |
April 03, 2024 | 566.62B |
April 02, 2024 | 564.25B |
April 01, 2024 | 569.12B |
March 28, 2024 | 572.91B |
March 27, 2024 | 571.35B |
March 26, 2024 | 577.43B |
March 25, 2024 | 575.82B |
March 22, 2024 | 574.53B |
March 21, 2024 | 579.33B |
March 20, 2024 | 581.70B |
March 19, 2024 | 586.20B |
March 18, 2024 | 592.99B |
March 15, 2024 | 590.67B |
March 14, 2024 | 600.55B |
March 13, 2024 | 595.69B |
March 12, 2024 | 602.92B |
March 11, 2024 | 585.65B |
March 08, 2024 | 593.82B |
March 07, 2024 | 606.56B |
March 06, 2024 | 556.71B |
March 05, 2024 | 556.27B |
March 04, 2024 | 570.99B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
111.20B
Minimum
May 16 2019
606.56B
Maximum
Mar 07 2024
251.59B
Average
231.32B
Median
Feb 08 2022
Market Cap Benchmarks
Amgen Inc | 165.46B |
AstraZeneca PLC | 240.07B |
GSK PLC | 92.10B |
Viking Therapeutics Inc | 7.978B |
Evaxion Biotech AS | 19.66M |
Market Cap Related Metrics
PE Ratio | 45.71 |
PS Ratio | 16.71 |
PEG Ratio | 0.8653 |
Price to Book Value | 41.23 |
Price to Free Cash Flow | 81.00 |
Price | 132.41 |
Earnings Yield | 2.19% |
PEGY Ratio | 0.8487 |
Operating PE Ratio | 37.29 |
Normalized PE Ratio | 45.71 |